Hetero to produce Russia’s COVID-19 vaccine in India
Published
More than 100 mn doses of Sputnik V to be made in a year
Full ArticlePublished
More than 100 mn doses of Sputnik V to be made in a year
Full ArticleThe Russian Direct Investment Fund (RDIF) and Hetero, one of India's generic pharmaceutical companies, have agreed to produce in..
Russia's sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in..